COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 1248: Articles 12471-12480  | Next

The Relationship of Vaccine Uptake and COVID-19 Infections among Nursing Home Staff and Residents in Missouri
Scroggins, S., Ellis, M., Shacham, E.
10.1101/2021.09.16.21263714 — Posted: 2021-09-21
Optimized Post-Vaccination Strategies and Preventative Measures for SARS-CoV-2
Pettit, R. W., Peng, B., Yu, P., Matos, P., Greninger, A. L., McCashin, J., Amos, C. I.
10.1101/2021.09.17.21263723 — Posted: 2021-09-21
Single-Dose SARS-CoV-2 Vaccination With BNT162b2 and AZD1222 Induce Disparate Th1 Responses and IgA Production
Müller, M., Volzke, J., Subin, B., Müller, S., Sombetzki, M., Reisinger, E. C., Müller-Hilke, B.
10.1101/2021.09.17.21263726 — Posted: 2021-09-21 Discussion: Onsite
COVID-19 vaccination rates among health care workers by immigrant background. A nation-wide registry study from Norway.
Kraft, K. B., Elgersma, I. H., Lyngstad, T. M., Elstrom, P., Telle, K. E.
10.1101/2021.09.17.21263619 — Posted: 2021-09-21
Deleterious drugs in COVID-19: a rapid systematic review and meta-analysis
Holder, M. W., Heeney, C., Malden, S., Perera, U., Sheikh, A.
10.1101/2021.09.17.21262724 — Posted: 2021-09-21
SARS-CoV-2 wastewater surveillance in Germany: long-term PCR monitoring, suitability of primer/probe combinations and biomarker stability
Ho, J., Stange, C., Suhrborg, R., Wurzbacher, C., Drewes, J. E., Tiehm, A.
10.1101/2021.09.16.21263575 — Posted: 2021-09-21
Influence of Built Environment on Bike Sharing Usage under COVID-19
Yang, H., Guo, Z., Huo, J., Yang, L.
10.1101/2021.09.17.21263721 — Posted: 2021-09-21
SARS-CoV-2 epidemic in the South American Southern cone: can combined immunity from vaccination and infection prevent the spread of Gamma and Lambda variants while easing restrictions?
Fiori, M., Bello, G., Wschebor, N., Lecumberry, F., Ferragut, A., Mordecki, E.
10.1101/2021.09.16.21263701 — Posted: 2021-09-21
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
Yorsaeng, R., Suntronwong, N., Phowatthanasathian, H., Assawakosri, S., Kanokudom, S., Thongmee, T., Vichaiwattana, P., Auphimai, C., Wongsrisang, L., Srimuan, D., Thatsanatorn, T., Klinfueng, S., Sudhinaraset, N., Wanlapakorn, N., Poovorawan, Y.
10.1101/2021.09.16.21263692 — Posted: 2021-09-21
The longitudinal kinetics of antibodies in COVID-19 recovered patients over 14 months
Eyran, T., Vaisman-Mentesh, A., Dror, Y., Aizik, L., Kigel, A., Rosenstein, S., Bahar, Y., Taussig, D., Tur-Kaspa, R., Kournos, T., Markovitch, D., Dicker, D., Wine, Y.
10.1101/2021.09.16.21263693 — Posted: 2021-09-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).